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Background
Vascular Endothelial Growth Factor A164/5 (VEGF
A164/5) expression correlated both temporally and
spatially with the proliferation of new blood vessels that
differ from normal blood vessels with respect to organi-
zation, structure, and function [1]. The aim of our study
was to measure plasma and wound fluid VEGF levels to
investigate the role of this angiogenic factor as a possi-
ble marker of leg ulcers healing in patients with chronic
venous disease.
Materials and methods
Design: Analysis of a prospective collected database.
Setting: Vascular Surgery Unit in an University Hospital.
Patients: A total of 37 patients aged >65. Study Group:
17 patients affected by venous leg ulcers (CEAP 6; at
l e a s tf r o m4w e e k sa n dn o to v e r2 4m o n t h s );C o n t r o l
Group: 20 persons with no clinical evidence of venous
or arterial disease of the lower limb. Data collection:
main demographic and laboratory parameters were
collected for all patients. Study Group: plasma and
wound fluid sample for VEGF A164/5 dosage (ELISA
assay), together with wound dimension recording were
performed at specific time-points: baseline measure-
ment, at inclusion (T0); 4 weeks after inclusion (T1) and
8 weeks after inclusion (T2). Control Group: a single
plasma sample was performed at T0.
Results
No differences in main demographic and laboratory para-
meters (p=NS for all measurements). At baseline the
median plasma VEGF levels (pg/ml) were significantly
higher in patients (98 pg/ml) than controls (54 pg/ml):
median difference vs. controls (95% CI) 35 (9–63). No
significance was found in patients between plasma VEGF
levels and ulcer size (p=0.179 at T0; p=0.212 at T1;
p=0.862 at T2). VEGF concentration in wound fluid
showed a statistically significant correlation with the
wound area (cm
2) (p=0.019 at T1; p=0.028 at T2).
Conclusions
Our results show that the VEGF165 level detected in
wound fluid can be of prognostic value for differentiat-
ing an effective or impaired wound healing response
while the difference observed in VEGF plasma levels
need further investigations.
Author details
1PhD Programme in Clinical and Experimental Biotechnology in Vein and
Lymphatics Disease.
2Department of General Surgery, University of
Catanzaro, Catanzaro, Italy.
Published: 19 May 2010
Reference
1. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA,
Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF: Vascular
permeability factor/vascular endothelial growth factor induces
lymphangiogenesis as well as angiogenesis. J Exp Med 2002,
196(11):1497-506.
doi:10.1186/1471-2318-10-S1-A64
Cite this article as: Longo et al.: VEG F as a biological marker of the
venous disease-associated ulcers natural history in the elderly:
preliminary data. BMC Geriatrics 2010 10(Suppl 1):A64.
1PhD Programme in Clinical and Experimental Biotechnology in Vein and
Lymphatics Disease
Longo et al. BMC Geriatrics 2010, 10(Suppl 1):A64
http://www.biomedcentral.com/1471-2318/10/S1/A64
© 2010 Longo et al; licensee BioMed Central Ltd.